Aspergillosis Diagnostics
MDVI measures therapeutic response to antifungal therapy in invasive pulmonary aspergillosis
Published in TB and Outbreaks Week, June 13th, 2006
According to a study from the United States, "Pulmonary infiltrates in neutropenic hosts with invasive pulmonary aspergillosis are caused by vascular invasion, hemorrhagic infarction, and tissue necrosis. Monitoring the dynamics of pulmonary infiltrates of invasive aspergillosis is an important tool for assessing response to antifungal therapy.
"We, therefore, introduced a multidimensional volumetric imaging (MDVI) method for analysis of the response of the volume of pulmonary infiltrates over time to antifungal therapy in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Diabetes & Tuberculosis
Diabetes is a risk factor for tuberculosis - Gonorrhea Epidemiology
Prolyliminopeptidase-negative N. gonorrhoeae strains followed an epidemic growth curve - Melioidosis Outbreaks
Extreme weather events associated with melioidosis case-clusters in Australia - Norovirus Outbreaks
Major shift of predominant norovirus strain coincided with new variant of genogroup II4 - Vibrio Cholerae
Toxigenic Vibrio cholerae detected in aquatic environment in Bangladesh - Antimicrobial Drug Development
Passifloricin analogues have antimalarial and antimycobacterial activity - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
